Specifically, these factors include larger tumor size (P = .004), elevated BCLC stage (P = .002) or higher Child stage (P = .024), decreased FAM96B expression (P = .002), and the presence of distant metastasis (P = .006). The gene discussed is CIAO2B; the disease is neoplasm.